BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 15048073)

  • 1. Induction of hTERT expression and phosphorylation by estrogen via Akt cascade in human ovarian cancer cell lines.
    Kimura A; Ohmichi M; Kawagoe J; Kyo S; Mabuchi S; Takahashi T; Ohshima C; Arimoto-Ishida E; Nishio Y; Inoue M; Kurachi H; Tasaka K; Murata Y
    Oncogene; 2004 Jun; 23(26):4505-15. PubMed ID: 15048073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raloxifene inhibits estrogen-induced up-regulation of telomerase activity in a human breast cancer cell line.
    Kawagoe J; Ohmichi M; Takahashi T; Ohshima C; Mabuchi S; Takahashi K; Igarashi H; Mori-Abe A; Saitoh M; Du B; Ohta T; Kimura A; Kyo S; Inoue M; Kurachi H
    J Biol Chem; 2003 Oct; 278(44):43363-72. PubMed ID: 12917431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of estradiol on estrogen receptor-alpha gene expression and activity can be modulated by the ErbB2/PI 3-K/Akt pathway.
    Stoica GE; Franke TF; Moroni M; Mueller S; Morgan E; Iann MC; Winder AD; Reiter R; Wellstein A; Martin MB; Stoica A
    Oncogene; 2003 Sep; 22(39):7998-8011. PubMed ID: 12970748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-2 increases human telomerase reverse transcriptase activity transcriptionally and posttranslationally through phosphatidylinositol 3'-kinase/Akt, heat shock protein 90, and mammalian target of rapamycin in transformed NK cells.
    Kawauchi K; Ihjima K; Yamada O
    J Immunol; 2005 May; 174(9):5261-9. PubMed ID: 15843522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone deacetylase inhibitor AR42 regulates telomerase activity in human glioma cells via an Akt-dependent mechanism.
    Yang YL; Huang PH; Chiu HC; Kulp SK; Chen CS; Kuo CJ; Chen HD; Chen CS
    Biochem Biophys Res Commun; 2013 May; 435(1):107-12. PubMed ID: 23624506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Raloxifene increases proliferation and up-regulates telomerase activity in human umbilical vein endothelial cells.
    Doshida M; Ohmichi M; Tsutsumi S; Kawagoe J; Takahashi T; Du B; Mori-Abe A; Ohta T; Saitoh-Sekiguchi M; Takahashi K; Kurachi H
    J Biol Chem; 2006 Aug; 281(34):24270-8. PubMed ID: 16798746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Both estrogen and raloxifene protect against beta-amyloid-induced neurotoxicity in estrogen receptor alpha-transfected PC12 cells by activation of telomerase activity via Akt cascade.
    Du B; Ohmichi M; Takahashi K; Kawagoe J; Ohshima C; Igarashi H; Mori-Abe A; Saitoh M; Ohta T; Ohishi A; Doshida M; Tezuka N; Takahashi T; Kurachi H
    J Endocrinol; 2004 Dec; 183(3):605-15. PubMed ID: 15590986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estradiol rapidly activates Akt via the ErbB2 signaling pathway.
    Stoica GE; Franke TF; Wellstein A; Czubayko F; List HJ; Reiter R; Morgan E; Martin MB; Stoica A
    Mol Endocrinol; 2003 May; 17(5):818-30. PubMed ID: 12554767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AND-34 activates phosphatidylinositol 3-kinase and induces anti-estrogen resistance in a SH2 and GDP exchange factor-like domain-dependent manner.
    Felekkis KN; Narsimhan RP; Near R; Castro AF; Zheng Y; Quilliam LA; Lerner A
    Mol Cancer Res; 2005 Jan; 3(1):32-41. PubMed ID: 15671247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of COX-2 protein expression by Akt in endometrial cancer cells is mediated through NF-kappaB/IkappaB pathway.
    St-Germain ME; Gagnon V; Parent S; Asselin E
    Mol Cancer; 2004 Mar; 3():7. PubMed ID: 15016316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of inhibitor of nuclear factor-kappaB phosphorylation increases the efficacy of paclitaxel in in vitro and in vivo ovarian cancer models.
    Mabuchi S; Ohmichi M; Nishio Y; Hayasaka T; Kimura A; Ohta T; Kawagoe J; Takahashi K; Yada-Hashimoto N; Seino-Noda H; Sakata M; Motoyama T; Kurachi H; Testa JR; Tasaka K; Murata Y
    Clin Cancer Res; 2004 Nov; 10(22):7645-54. PubMed ID: 15569997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen activates telomerase.
    Kyo S; Takakura M; Kanaya T; Zhuo W; Fujimoto K; Nishio Y; Orimo A; Inoue M
    Cancer Res; 1999 Dec; 59(23):5917-21. PubMed ID: 10606235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen-receptor-dependent regulation of telomerase activity in human endometrial cancer cell lines.
    Boggess JF; Zhou C; Bae-Jump VL; Gehrig PA; Whang YE
    Gynecol Oncol; 2006 Nov; 103(2):417-24. PubMed ID: 16690106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitogenic activity of estrogens in human breast cancer cells does not rely on direct induction of mitogen-activated protein kinase/extracellularly regulated kinase or phosphatidylinositol 3-kinase.
    Gaben AM; Saucier C; Bedin M; Redeuilh G; Mester J
    Mol Endocrinol; 2004 Nov; 18(11):2700-13. PubMed ID: 15297603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance.
    Campbell RA; Bhat-Nakshatri P; Patel NM; Constantinidou D; Ali S; Nakshatri H
    J Biol Chem; 2001 Mar; 276(13):9817-24. PubMed ID: 11139588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteopontin stimulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through phosphatidylinositol 3-kinase/Akt signaling pathways in breast cancer cells.
    Das R; Mahabeleshwar GH; Kundu GC
    J Biol Chem; 2003 Aug; 278(31):28593-606. PubMed ID: 12771144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of BAD phosphorylation either at serine 112 via extracellular signal-regulated protein kinase cascade or at serine 136 via Akt cascade sensitizes human ovarian cancer cells to cisplatin.
    Hayakawa J; Ohmichi M; Kurachi H; Kanda Y; Hisamoto K; Nishio Y; Adachi K; Tasaka K; Kanzaki T; Murata Y
    Cancer Res; 2000 Nov; 60(21):5988-94. PubMed ID: 11085518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genistein represses telomerase activity via both transcriptional and posttranslational mechanisms in human prostate cancer cells.
    Jagadeesh S; Kyo S; Banerjee PP
    Cancer Res; 2006 Feb; 66(4):2107-15. PubMed ID: 16489011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4-Hydroxy estradiol but not 2-hydroxy estradiol induces expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor A through phosphatidylinositol 3-kinase/Akt/FRAP pathway in OVCAR-3 and A2780-CP70 human ovarian carcinoma cells.
    Gao N; Nester RA; Sarkar MA
    Toxicol Appl Pharmacol; 2004 Apr; 196(1):124-35. PubMed ID: 15050414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor up-regulates expression of transforming growth factor beta receptor type II in human dermal fibroblasts by phosphoinositide 3-kinase/Akt signaling pathway: Resistance to epidermal growth factor stimulation in scleroderma fibroblasts.
    Yamane K; Ihn H; Tamaki K
    Arthritis Rheum; 2003 Jun; 48(6):1652-66. PubMed ID: 12794834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.